PFAS: More Than “Forever Chemicals”
Per‑ and polyfluoroalkyl substances (PFAS) don’t just linger in the environment—they accumulate in people. Mounting research now ties this chemical family to serious health threats, prompting regulators and businesses worldwide to act.
How PFAS Impact Human Health
- Cancer – National Cancer Institute and Harvard studies link PFOA (a PFAS variant) to kidney and testicular cancers.
- Immune Suppression – National Institute of Environmental Health Sciences data show weakened vaccine response and reduced immunity.
- Reproductive & Developmental Harm – CDC and EPA research connects prenatal PFAS exposure to lower birth weights, developmental delays, and fertility challenges.
- Liver & Metabolic Damage – Multiple studies associate PFAS with liver disease, high cholesterol, obesity, and diabetes.
Real‑World Evidence & Regulatory Action
- DuPont & 3M Lawsuits – Multi‑billion‑dollar settlements over widespread contamination confirm PFAS‑related harm. In 2021, 3M faced an average of three PFAS lawsuits per day, a pace that continues.
- CDC National Exposure Report – Detects PFAS in the blood of 97 % of Americans, spotlighting the scale of exposure.
- EU Persistent Organic Pollutants (POP) Regulation – Bans several PFAS, including PFOA, in finished and semi‑finished products.
- EU REACH Annex XVII – Restricts PFOA, PFHxA, and related substances in manufacturing, use, and sale.
Why Industry Should Care
Unchecked PFAS can trigger product recalls, steep fines, and brand damage. Evolving regulations demand rigorous visibility into material supply chains—and fast action when PFAS are detected.
How EcoPulse Can Help
Our PFAS AI™ platform leverages advanced models and a proprietary chemical database to pinpoint PFAS across complex supply chains, quantify risk, and guide mitigation—so manufacturers stay compliant and protect both people and profitability.